Tuesday, December 19, 2017

Weds Cure Talk: Targeting Stem Cells in Multiple Myeloma for Improved Outcomes

Multiple myeloma remains incurable despite improved remissions with novel agents. Relapse eventually occurs in the form of a drug-resistant disease that carries a dismal prognosis. Relapse is dependent on stem cell functions. We are talking to Dr. William Matsui of Johns Hopkins University School of Medicine to get a better understanding of the drivers of these functions and how they may lead to novel therapies for relapsed disease. 





No comments:

Post a Comment

What is The Difference Between Terminal and Incurable Cancer?

Today's read: Incurable vs Terminal